Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States
Industries Focus
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Healthcare IT
Investment Size:
50,000 to 10,000,000 USD
Investor Details Founded: 2001
Latterell Venture Partners is a venture capital firm specializing in early-stage healthcare investments, focusing on sectors such as biotechnology, pharmaceuticals, medical devices, healthcare IT, and diagnostics. The firm was established in 2001 and has committed over $300 million in capital to support innovative healthcare startups.
The firm's investment strategy involves initial investments ranging from $50,000 to $10 million, with the potential for subsequent equity financings of $10 to $20 million per portfolio company. Latterell Venture Partners typically leads or co-leads investments and often takes board seats to actively support the growth and success of its portfolio companies.
The team comprises professionals with extensive experience in biomedical products and venture capital, collectively having over 150 years of experience and involvement with more than 100 biomedical startup companies. This expertise enables them to provide valuable guidance and resources to entrepreneurs in the healthcare sector.
Requirements
- Innovative technologies
- Large market opportunities
- Passionate entrepreneurs
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Cellective Therapeutics
- HemaQuest Pharmaceuticals
- Naurex
- Transcend Medical
- Viracta Therapeutics
Mentioned In
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$14.95
-
$39.95
-
$99.00
-
$299.00
Claim this Investor
Are you an official representative of Latterell Venture Partners?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim